FIGURE 1 Morphological and molecular analysis ofFH-deficient renal cell carcinoma
(A) Pedigree. (B) Enhanced computed tomography. (C) Positron emission tomography with 18F fluorodeoxyglucose. (D) Left kidney tumor sections were stained with hematoxylin and eosin staining. (E) Immunohistochemical staining is negative for FH. (F) Sanger sequencing: proband tumor, proband peripheral blood, peripheral blood of the patient’s father, and peripheral blood of the patient’s mother.